Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Other Operating Expenses (2023 - 2025)

Historic Other Operating Expenses for Onconetix (ONCO) over the last 3 years, with Q2 2025 value amounting to $594000.0.

  • Onconetix's Other Operating Expenses fell 9483.39% to $594000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $38.7 million, marking a year-over-year decrease of 826.93%. This contributed to the annual value of $315688.0 for FY2024, which is 9918.17% down from last year.
  • According to the latest figures from Q2 2025, Onconetix's Other Operating Expenses is $594000.0, which was down 9483.39% from $10.9 million recorded in Q1 2025.
  • In the past 5 years, Onconetix's Other Operating Expenses registered a high of $27.2 million during Q4 2024, and its lowest value of $594000.0 during Q2 2025.
  • For the 3-year period, Onconetix's Other Operating Expenses averaged around $11.7 million, with its median value being $9.2 million (2024).
  • As far as peak fluctuations go, Onconetix's Other Operating Expenses skyrocketed by 6024.46% in 2024, and later crashed by 9483.39% in 2025.
  • Over the past 3 years, Onconetix's Other Operating Expenses (Quarter) stood at $23.2 million in 2023, then rose by 17.18% to $27.2 million in 2024, then crashed by 97.81% to $594000.0 in 2025.
  • Its Other Operating Expenses was $594000.0 in Q2 2025, compared to $10.9 million in Q1 2025 and $27.2 million in Q4 2024.